"We are an ophthalmology practice specializing in the diagnosis and management of diseases of the retina and vitreous. Our board-certified physicians have completed a 2 year fellowship focusing on the management of: Macular Degeneration, Diabetic Retinopathy, Retinal vascular disease, Retinal Detachment, Retinal Tears, Flashes and floaters, Macular hole, and Macular pucker. We are fellowship-trained in the medical and surgical management of these conditions. We have experienced technical staff who are experts in helping our physicians manage these conditions. We use the latest in diagnostic and surgical technology to bring the best care possible to our patients. We are available 24/7 and provide local retina emergency coverage."

During the past decade, Retina Associates of Michigan conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of Michigan" #1 collaborator was "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates of Michigan" are "Diabetic Macular Edema" (1 trials), "Dry Age-related Macular Degeneration" (1 trials), "Non-proliferative Diabetic Retinopathy" (1 trials) and "Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Retina Associates of Michigan" in a lesser frequency.

Most popular intervention types in "Retina Associates of Michigan" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (1 trials), "GT005: High Dose" (1 trials), "GT005: Medium Dose" (1 trials), "OPL-0401 Dose 1" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of Michigan" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of Michigan". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Retina Associates of Michigan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of Michigan, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".